Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00220454Phase 2Completed
Phase 2, randomised, double-blind trial of estradiol and hydrocortisone in menopause (4 arms), sponsored by Seattle Institute for Biomedical and Clinical Research. Primary endpoint: Change in cognitive test scores at 3 months. Started Dec 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00220454.